FiercePharma: IMS sees little drug spending impact from shift to managed Medicaid plans

A recent study from the IMS Institute for Healthcare Informatics suggests the recent shift in some Medicaid plans from a fee-for-service model to a managed-care system has not delivered on highly-touted savings on prescription drugs.  Read More…